RÉSUMÉ
ObjectiveTo study the expression and potential significance of NET-1 in endometrial carcinoma.Methods106 specimens after operation were selected.All specimens were stained with H.E.and immunohistochemistry.ResultsThe expression of NET-1 immunoreactivity were different in normal endometrium(43.8% ),endometrial hyperplasia ( 79.2% ) and endometrial carcinoma ( 100% ) ( x2 =11.88,P < 0.01 ).The expression of NET-1 in endometrial carcinoma was significantly higher than that in normal endometrium and simple endometrial hyperplasia ( x2 =36.14,10.86,P < 0.01 ).The expression of NET-1 in endometrial hyperplasia was significantly higher than that in normal endometrium ( x2 =5.29,P< 0.05 ).There was a correlation between the expression of NET-1 and degree of endometrial lesions ( r =0.355,P <0.01 ).The expression of NET-1 was relative with differentiation (x2 =11.04,P <0.01 ; r =0.558,P <0.01),stages(x2 =11.04,P <0.01; r =0.558,P <0.01),depth of myometrial invasion (x2 =15.90,P <0.01 ; r =0.479,P <0.01),with or without metastasis in lymph node ( Z =-3.74,P <0.01 ),menopause condition ( Z.=-2.60,P <0.01).ConclusionsNET-1 may play an important role in carcinogenesis and progression of endometrial carcinoma.It might be a marker of biological behavior and reference for endometrial carcinoma gene therapy.
RÉSUMÉ
Micrometastasis of carcinoma is one of the most significant pieces of evidence for molecular staging.Detection of micrometastasis of non-small-cell lung cancer plays a significant role in staging precisely,guiding treatment and predicting the prognosis of patients.This review is focused on the latest developments of markers such as CK19,LUNX,CEA mRNA,oncogene and anti-oncogene.The sites about micrometastasis of non-small-cell lung cancer are usually reported in lymph node and bone marrow,rarely in pleural cavity and increasingly in peripheral blood.